MoneyWorks4Me

Themis Medicare - Quaterly Results

12 Nov 2021 Evaluate
The Top line for the quarter ended September 2021 of Rs. 1073.91 millions up 95.64% from Rs. 548.92 millions.The company almost doubled its revenue to Rs. 151.21 millions  from Rs. 56.82 millions in the quarter ended September 2021.Operating profit surged to 236.75 millions from the corresponding previous quarter of 118.50 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 1073.91 548.92 95.64 2198.95 1033.80 112.71 2306.70 2015.88 14.43
Other Income 2.13 21.31 -90.00 5.62 24.90 -77.43 36.22 34.71 4.35
PBIDT 236.75 118.50 99.79 644.99 245.07 163.19 535.05 391.53 36.66
Interest 20.52 37.08 -44.66 47.21 67.03 -29.57 127.12 128.80 -1.30
PBDT 216.23 81.42 165.57 597.78 178.04 235.76 407.93 262.73 55.27
Depreciation 23.75 20.40 16.42 47.25 40.78 15.87 85.46 82.68 3.36
PBT 192.48 61.02 215.44 550.53 137.26 301.09 322.47 180.05 79.10
TAX 41.27 4.20 882.62 131.98 24.01 449.69 56.28 20.93 168.90
Deferred Tax 8.77 4.20 108.81 34.48 24.01 43.61 56.28 20.93 168.90
PAT 151.21 56.82 166.12 418.55 113.25 269.58 266.19 159.12 67.29
Equity 91.99 91.89 0.11 91.99 91.89 0.11 91.88 91.88 0.00
PBIDTM(%) 22.05 21.59 2.12 29.33 23.71 23.73 23.20 19.42 19.43
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..